Although the microtubule (MT) cytoskeleton has been shown to facilitate nuclear import of specific cancer regulatory proteins, including p53, pRb, and parathyroid hormone related protein (PTHrP), the MTassociation sequences (MTASs) responsible, and the nature of the interplay between MTdependent and conventional importin (IMP)-dependent nuclear translocation, are unknown. Here we use site-directed mutagenesis, live cell imaging, and direct IMP-and MT-binding assays to map the MTAS of PTHrP for the first time, finding that it is within a short modular region of PTHrP (residues 82-108) that overlaps with PTHrP's IMPβ1-recognised nuclear localization signal (residues 66-108). Importantly, FRAP experiments indicate that disruption of the MT network or mutation of PTHrP's MTAS decreases the rate of nuclear import by 2-fold. Moreover, MTAS functions depend on mutual exclusivity of binding of PTHrP to MTs and IMPβ1 such that, following MT-dependent trafficking towards the nucleus, perinuclear PTHrP can be displaced from MTs by IMPβ1 prior to import into the nucleus. This is the first molecular definition of a MTAS that facilitates protein nuclear import, as well as the first delineation of the mechanism whereby cargo is transferred directly from the cytoskeleton to the cellular nuclear import apparatus.
Although the microtubule (MT) cytoskeleton has been shown to facilitate nuclear import of specific cancer regulatory proteins, including p53, pRb, and parathyroid hormone related protein (PTHrP), the MTassociation sequences (MTASs) responsible, and the nature of the interplay between MTdependent and conventional importin (IMP)-dependent nuclear translocation, are unknown. Here we use site-directed mutagenesis, live cell imaging, and direct IMP-and MT-binding assays to map the MTAS of PTHrP for the first time, finding that it is within a short modular region of PTHrP (residues 82-108) that overlaps with PTHrP's IMPβ1-recognised nuclear localization signal (residues 66-108). Importantly, FRAP experiments indicate that disruption of the MT network or mutation of PTHrP's MTAS decreases the rate of nuclear import by 2-fold. Moreover, MTAS functions depend on mutual exclusivity of binding of PTHrP to MTs and IMPβ1 such that, following MT-dependent trafficking towards the nucleus, perinuclear PTHrP can be displaced from MTs by IMPβ1 prior to import into the nucleus. This is the first molecular definition of a MTAS that facilitates protein nuclear import, as well as the first delineation of the mechanism whereby cargo is transferred directly from the cytoskeleton to the cellular nuclear import apparatus.
The results have broad significance with respect to fundamental processes regulating cell physiology/ transformation.
Nuclear localization of many cancerregulatory proteins is integral to their function (1) (2) (3) (4) (5) (6) , in the same way that efficient subcellular trafficking of viruses/viral particles is crucial for pathogenicity (7, 8) . Nuclear protein import is generally accepted to be independent of the cytoskeleton (9) , conventionally being mediated by soluble transport factors (importins, IMPs) which promote the passage of cargoes bearing nuclear localization signals (NLSs) through the nuclear envelope-localized nuclear pore complex (NPC). It is becoming increasingly apparent, however, that specific cancer-related proteins, such as the tumor suppressors p53 (4) and retinoblastoma protein (Rb) (9) , and the paracrine/autocrine signaling molecule parathyroid hormone related protein (PTHrP) (10) , rely on the MT network for efficient nuclear import, as do certain transcription factors (eg. STATs 1, and 5) (11, 12) . PTHrP is a crucial factor in the early stages of development of various tissues, as well as in the biology of adult tissues (13, 14) . Importantly, it is present as a circulating factor in numerous types of tumors (15) , with its malignant actions linked to its nuclear localization (2, 3) , that, significantly, is known to be dependent on the IMP family member IMPβ1, as well as MT-integrity (10) .
Specific nuclear localizing proteins such as PTHrP appear to possess the ability to interact with MTs for facilitated transport through the cytoplasm prior to conventional IMP-dependent import through the NPC into the nucleus (9, 16, 17) . However, neither the sequences responsible for mediating MT association and facilitation of nuclear import (microtubule association sequences or MTASs), nor the mechanisms underlying cargo uncoupling from the MTs for IMP interaction and subsequent nuclear import, have been defined. Here we use site-directed mutagenesis, live cell imaging approaches/fluorescence recovery after photobleaching (FRAP) analysis, and novel in vitro binding assays to define for the first time the minimal sequence within PTHrP that is functional both in terms of MT-association and MT-dependent enhancement of nuclear import. This represents the first MTAS described for any protein.
Significantly, our results provide the first insight into the mechanism by which MTAScontaining proteins can interact with MTs to enhance delivery to the perinuclear region of the cell, prior to displacement from the MTs for subsequent nuclear transport. The findings have clear significance to basic processes in cell biology with relevance both to cellular physiology and transformation.
EXPERIMENTAL PROCEDURES
Generation of expression constructs for GFPPTHrP fusion cassettes, and site directed mutagenesis-PTHrP coding sequences were inserted to the C-terminus of enhanced green fluorescent protein (EGFP). PTHrP FL and its truncated derivatives: 1-108, 38-108, 38-141 were inserted into the episomally replicating Gateway TM compatible pEPI-DESTC plasmid (18), using the Gateway TM recombination system (Invitrogen , were generated using the QuikChange site-directed mutagenesis kit (Stratagene).
PTHrP residues 66-108 and mutant derivatives thereof, 82-108, and 66-94 were also inserted into plasmid pMH830 (19) , between the coding sequences of GFP and β galactosidase (βgal), and at the C-terminus of 6xHis-tagged-GFP in the Gateway TM compatible plasmid pGFPRfB (20) for bacterial expression and protein purification. Cell culture, transfection and drug treatments-COS-7 and U2 OS cells were maintained in Dulbeccos's Modified Eagle's Medium (DMEM) and McCoy's medium respectively, supplemented with 10% FCS, in a 5% CO 2 atmosphere at 37 o C. COS-7 cells at 70-80% confluence were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. In some experiments, cells were grown in the absence or presence of 5 µg/ml nocodazole (NCZ) (Sigma), 1 µg/ml of taxol (Sigma) for 4 h, or 0.5 µg/ml cytochalasin D (CD) (Sigma) for 3 h, prior to analysis.
Confocal laser scanning microscopy (CLSM)
and image analysis-Cells were routinely imaged 20-24 h post transfection by CLSM using a BioRad MRC-600 microscope. Live cell imaging was performed using a 40X water immersion objective on a 37 o C heated stage, whereas fixed cells were imaged using a 60X oil immersion objective. Image analysis was carried out on the digitalised confocal files using the Image J 1.38 public domain software (NIH) (9, (21) (22) (23) ). An area of the nucleolus or nucleus (not including the nucleolus), and cytoplasm were selected to determine the relative nucleolar (Fnu), nuclear (Fn) and cytoplasmic (Fc) concentrations of GFP-fusion proteins after correction for background fluorescence (Fb), enabling the nucleolar (Fnu/c) or nuclear (Fn/c) to cytoplasmic fluorescence ratios to be calculated (10, 24, 25) . Results were expressed for a minimum of 40 cells, and experiments were repeated at least twice.
For MT or actin staining, cells were fixed and stained with anti-β-tubulin (1/500 dilution, Cytoskeleton) followed by Alexa TM 568-coupled secondary antibodies (1/1000 dilution; Invitrogen), or with Alexa 594-labelled phalloidin (1/850 dilution; Invitrogen), respectively.
To investigate the subcellular localization of endogenous proteins, cells were fixed and immunostained as previously (9) using specific anti-PTHrP (1/500 dilution, Genway) or anti-Tag (SV40 large T antigen) (1/1000 dilution, Santa Cruz Biotechnology) primary and Alexa 488-coupled secondary antibodies. Quantitative analysis was performed as above, with background values obtained from cells stained only with secondary antibody (26). For statistical analysis, raw data was analyzed using the GraphPad InStat 3 software and a two-tailed unpaired t test was applied for samples with similar standard deviation (SD), or a MannWhitney test for samples with significantly different SDs, where p values < 0.05 were considered significant. FRAP-FRAP was performed essentially as previously (9) . Briefly, COS-7 cells transiently expressing GFP-PTHrP fusion proteins were imaged using an Olympus Fluoview 1000 microscope equipped with an Argon ion laser (40 mW), and 100X oil immersion lens (Nikon) in combination with a heated stage. Prior to bleaching, three images were collected using 3% of total laser power with excitation at 488 nm, scanning an area of 126 µm 2 at a rate of 8 µs/pixel. Nuclear bleaching was performed in an area covering almost the whole nucleus (approximately 12 µm 2 ), scanning the area 10 times at a rate of 12.5 µs/pixel, and applying 80% of the laser power. After bleaching, the cells were immediately scanned and fluorescence recovery monitored by acquiring images at 20 s intervals over a period of 9 min using detector and laser settings identical to those used prior to photobleaching. Image analysis was performed as above to determine the Fn and Fc values at all time intervals during the photobleaching experiment. Results were then expressed as fractional recovery of Fn/c (Fn/c of respective time points divided by the corresponding prebleach value), and data fitted exponentially according to the formula y = a(1-e -bx ), as previously (9, 16, 22, (27) (28) (29) (30) (31) to determine the maximal recovery and half-time (t 1/2 ). Results for Fc between 20 and 120 s were used to determine the rate of cytoplasmic decay (31). Protein expression and purification-All His 6 GFP-PTHrP fusion proteins were expressed in E. coli host strain BL21(DE3)/pREP4. Cultures grown at 28 o C to an OD 600 of 0.6 were induced with 1 mM IPTG for 4 h. Pellets were lysed in native buffer (50 mM NaH 2 PO 4 , 600 mM NaCl, pH 8.0) containing 10 mM imidazole, 5 mg/ml lysozyme 1 unit/ml DNase, 1% Triton, and Complete™ EDTA-free protease inhibitors (Roche). Proteins were purified using the Ni-NTA system (Qiagen) by incubating Ni-NTA beads with cleared lysate for 2 h at 4 o C, before elution with native buffer containing 500 mM imidazole. The imidazole was removed by dialysis.
His 6 GFP alone (expressed from plasmid pTRCA-EGFP) (32), His 6 GFP-T-ag (T-ag residues 110-135, including the NLS and flanking protein kinase CK2 phosphorylation site), and His 6 GFP-PTHrP derivatives to be used for MT binding assays, were purified under denaturing conditions as previously (20, 32), and slowly refolded on the column by gradually decreasing the urea concentration. His 6 GFPPTHrP derivatives were eluted in 200 mM NaCl, 50 mM NaH 2 PO 4, (pH 8.0), using 200 mM imidazole, before dialysis to remove imidazole, and subjected to affinity chromatography using a Hi-trap heparin HP column (GE) by FPLC, with elution by salt gradient. The protein fractions were transferred to 450 mM KCl, 80 mM HEPES buffer (pH 8.0) and concentrated by microfiltration.
IMPs were purified as GST fusion proteins as described (21, 33). For ALPHAScreen assays, IMP proteins were biotinylated using the Sulfo-NHS-Biotin reagent (Pierce). Briefly, 3. 15 µM of PTHrP and control proteins were incubated with 10 µl of polymerized MTs for 1 h before the mix of MTs and GFP-fusion proteins was visualized on a slide using a Leica AF6000 LX microscope (Leica) with 40X objective. In some experiments, PTHrP was pre-incubated with 3 µM IMPs at room temperature for 30 min prior to MT incubation, or IMPs added 10 min prior to imaging following 1h pre-incubation of PTHrP with MTs. In some cases, MTs were visualized using the Bio-Rad MRC-600 CLSM with a 60X oil immersion lens, and image analysis on the digitalised confocal files was performed using Image J 1.38, where a line plot was used to quantify the specific MT-associated fluorescence (Fmt) with background fluorescence subtracted (35). MT association in vivo assay-MT and associated proteins were extracted from COS-7 cells expressing GFP-PTHrP fusion proteins using the MT/Tubulin In Vivo Assay Kit (BK038, Cytokeleton) as described (36). Briefly, COS-7 cells transfected to express recombinant GFP-PTHrP constructs, GFP alone, and/or human myc-IMPβ1, were lysed using MT stabilizing buffer containing 100 µM GTP, 1 mM ATP, and 10 µl/ml protease inhibitor cocktail, by incubation for 10 min at 37 o C. MTs and associated proteins (pellet, P) were harvested by ultracentrifugation at 55,000 x g for 30 min at 37 o C and separated from the supernantant (S) (containing soluble tubulin and non MT associated proteins), after washing (W) three times with MT stabilizing buffer. The P, W and S fractions were analyzed by Western blotting using anti-GFP (1/1000, Roche), anti-β-tubulin (1/500 dilution, Cytoskeleton), anti-IMPβ1 (1/1000, Cell Signaling), or anti-myc (1/1,000, Santa Cruz) antibodies. The blots were developed using chemiluminescence (Perkin Elmer), and densitometric analysis performed using the ImageQuant TL software (GE Healthcare Life Science). The signal intensities for GFP-fusion proteins in the P and S fractions were normalized to the internal control protein, tubulin. For single transfections, the normalized values were expressed as percentage of the intensity for the S fraction. In experiments where cells were cotransfected to express GFP-PTHrP-66-108 (or BASIC-1mut) and IMPβ1, the ratio of MT-associated to non-associated PTHrP protein (P/S) was calculated, and to quantify the effect of IMPβ1 coexpression, results were shown as a percentage of the P/S ratio from cells expressing GFP-PTHrP-66-108 alone.
RESULTS

PTHrP amino acids 82-108 are sufficient to confer MT-enhanced nuclear accumulation-
Although previous studies implicate an MTfacilitated nuclear import pathway for PTHrP (9, 10) , as well as for other specific proteins (9) , neither the mechanistic basis of MTenhancement nor the sequence (MTAS) responsible have been defined in any case. We firstly set out to map PTHrP's MTAS by generating a number of constructs encoding a series of GFP-fusion protein derivatives of PTHrP (Fig. 1A) . The nuclear accumulation of the derivatives was examined by live cell imaging of transfected cells without or with pretreatment with nocodazole (NCZ, Fig. 1BC ). Cells treated in parallel were also fixed and stained for tubulin, confirming that NCZ treatment caused large-scale disassembly of the MT cytoskeleton (Fig. 1B, lower panels) .
CLSM imaging revealed an increase in the cytoplasmic localisation of GFP-PTHrP full length (FL) (amino acids 1-141) and the truncated derivatives 38-141, 1-108, 38-108, 66-108 and 82-108 in cells lacking intact MTs (NCZ-treated cells), compared to non-treated cells containing intact MTs (Fig. 1B) . No change was observed for GFP-PTHrP-38-94, 66-94, and 94-108, or GFP itself. Quantitative analysis confirmed this observation, indicating a significant (p < 0.003) increase in cytoplasmic fluorescence (Fc) of the former group of proteins following NCZ treatment (up to almost 9-fold, in some cases, middle histogram). This was accompanied by decreases in the nuclear fluorescence (Fn) (Fig. 1C , left lower histogram), although the Fn was still higher than the Fc due to the presence/activity of the conventional NLS.
The nuclear to cytoplasmic fluorescence ratio (Fn/c) and nucleolar to cytoplasmic fluorescence ratio (Fnu/c) was calculated as previously (see Materials and Methods; Roth et al., 2007) , revealing that GFP-PTHrP-1-141, 38-141, 1-108, 38-108, 66-108 and 82-108 all showed significantly (p < 0.0001) reduced Fn/c and Fnu/c values in the absence compared with in the presence of functional MTs (right histograms). In contrast, NCZ treatment had no effect on the extent of nuclear/nucleolar accumulation of GFP-PTHrP-38-94, 66-94 or 94-108, or GFP itself (Fig. 1C) , implying a lack of MT-enhanced nuclear import, and suggesting that the MTAS is within the region 82-108. The fact that GFP-PTHrP-38-94 and 66-94 contain the previously identified IMPβ1-recognized NLS of PTHrP (24) but accumulate to a much lower extent than GFP-PTHrP-66-108 implies that the NLS may require additional residues (94-108) for optimal nuclear import efficiency in vivo. The additional sequence required, also appears to confer NCZ-sensitivity of nuclear/nucleolar accumulation. Thus, the sequence appears to be part of PTHrP's putative MTAS (amino acids 82-108), the minimal region able to confer MT-enhanced nuclear import by working in combination with the NLS to achieve maximal nuclear accumulation (see also below).
Nuclear accumulation of PTHrP 82-108 requires MT dynamics-MTs are intrinsically dynamic filaments essential for many cellular events. Drugs that affect MT dynamic behaviour and functionality, such as taxol-a MT stabilizing agent-have been shown to impair efficient nuclear import of several nuclear proteins, such as p53 (4) and Rb (9) . The effect of NCZ (above) is to disassemble the MT network. Thus, to test the role of MT dynamics more directly, we examined the effect of taxol on the nuclear accumulation of the GFP-PTHrP constructs. As a control, we also tested the effect of the actin-depolymerizing agent cytochalasin D (CD). The efficacy of these drug treatments in affecting MTs and actin were confirmed by treating cells in parallel and fixing/staining using an anti-β-tubulin antibody or phalloidin respectively (see Fig. 2A , lower panels).
Importantly, we found that the effect of taxol treatment on nuclear/nucleolar accumulation of the various GFP-PTHrP derivatives closely resembled that of NCZ, resulting in an increase in cytoplasmic localization of GFP-PTHrPfusions 1-141, 38-141, 1-108, 38-108, 66-108 and 82-108, when compared with that observed in non-treated cells (Fig. 2A) . The localization of GFP-PTHrP 66-94 or GFP alone was unaffected.
Quantitative analysis supported this observation, with significantly (p < 0.0002) reduced nuclear/nucleolar accumulation evident for all constructs following taxol treatment, except for GFP-PTHrP-66-94 and GFP alone (Fig. 2B) . These results clearly imply that efficient nuclear translocation conferred by PTHrP residues 82-108 requires a functional, dynamic MT network.
CD treatment, in contrast, had no effect on nuclear localization of any of the proteins examined (Fig. 2AB) , underlining the fact that efficient nuclear accumulation of PTHrP depends specifically on MTs, and not on actin filaments.
Two clusters of basic amino acids are critical for MT-dependent PTHrP nuclear import-To determine the specific residues within PTHrP amino acids 66-108 responsible for MTdependent nuclear import, we performed sitedirected mutagenesis of several specific sequences within the NLS/MTAS-containing region (see Fig. 3A ). PTHrP 66-108 contains two main basic regions (KKKK 91 ) and (KKRR 106 ), which are separated by a linker of 10 residues (GKPGKRKEQE 101 ), an arrangement that is characteristic of a bipartite NLS. Within the linker region there is also a sequence (KEQE 101 ) which has some resemblance to the association motif (K/RXTQT) for the dynein MT motor protein light chain 8 (DLC8) (37-39). To test the potential role of these 3 regions in PTHrP nuclear import, we generated derivatives of GFP-PTHrP-66-108 containing mutations in each of the basic amino acid clusters, KKKK COS-7 cells were transfected to express the various mutant derivatives as well as wild type (WT) GFP-PTHrP-66-108, prior to treatment without or with NCZ and imaging 20-24 h post transfection. In the absence of NCZ treatment, the BASIC-1mut and BASIC-2mut derivatives both showed increased cytoplasmic localization compared to WT, which was exclusively nuclear/nucleolar (Fig. 3C ). Quantitative analysis confirmed significantly (p < 0.0001) reduced nuclear/nucleolar accumulation for the BASIC-1mut and BASIC-2mut derivatives (Fn/c and Fnu/c of 2-3 and 4-6, respectively) (Fig. 3D ) compared to WT (values of 50 and 135, respectively).
That MT-dependent transport was directly affected by the basic cluster mutations was indicated by the fact that NCZ treatment did not further reduce nucleolar or nuclear accumulation (Fig. 3CD) , in contrast to the case of WT, where NCZ treatment caused a significant reduction of both. Thus, it appears that both KKKK 91 and KKRR 106 are critical for MT-enhanced nuclear import of PTHrP.
In contrast to the results for the basic cluster mutants, the LINKERmut derivative showed levels of nucleolar/nuclear accumulation more similar to that of WT, with values of Fnu/c and Fn/c of 60% that of the WT. This reduction however, did not appear to reflect an essential role for this sequence in efficient MT-facilitated import, as the nuclear accumulation of the LINKERmut derivative remained sensitive to NCZ. In fact, NCZ treatment significantly reduced its nuclear/nucleolar accumulation bringing it to the same level as that observed following NCZ treatment of WT (Fig. 3CD) .
PTHrP 66-108 can confer efficient MTfacilitated nuclear targeting of a large cargo protein, dependent on KKKK 91 and KKRR 106 -Molecules smaller than c. 45 kDa can enter the nucleus through the nuclear pore by passive diffusion (40). With a molecular weight of 33 kDa, GFP-PTHrP-66-108 is below this limit. To exclude the possibility that the various GFPPTHrP fusion proteins may enter the nucleus by passive diffusion and accumulate in the nucleus by binding to nuclear components (24), the sequences encoding PTHrP amino acids 66-108 (WT and mutant derivatives), as well as 82-108, 66-94, and 94-108 were inserted between the sequences encoding GFP and β-galactosidase (βgal) in the plasmid vector pMH830 (19) . The resulting tetrameric GFP-βgal fusion proteins (c. 580 kDa) absolutely require active nuclear transport for nuclear entry/accumulation (19) .
Strikingly, fusion proteins containing PTHrP 66-94 or 94-108 were completely cytoplasmic in transfected cells, comparable in all respects to GFP-βgal alone (Fn/c of c. 0.3; Fig. 4AB 
Mutation of either of the basic clusters severely reduced nuclear import of GFP-PTHrP-66-108-βgal, resulting in an absence of nucleolar accumulation, and 2-fold lower nuclear accumulation (Fn/c of 8) in the case of BASIC1mut or total abolition of nuclear accumulation (Fn/c of 0.2) in the case of BASIC-2mut (Fig.  4AB ). This indicates that both basic clusters contribute to active nuclear targeting of PTHrP, but that KKRR 106 is absolutely essential. Again in contrast to the effect of the basic cluster mutations, mutation of KEQE 101 (LINKERmut) had a negligible effect on nucleolar/nuclear localization of GFP-PTHrP66-108-βgal (Fig.  4AB) , consistent with the idea that this sequence is not essential for nuclear/nucleolar targeting (see above) (Fig. 3) .
Importantly, treatment with either NCZ or taxol significantly (p < 0.05) reduced nuclear/nucleolar accumulation of GFP-βgal fusions carrying PTHrP residues 66-108, and 82-108, as well as LINKERmut, resulting in a >50% decrease (Fig. 4AB) . This implies dependence of all of these proteins on MT functionality/dynamics for optimal nuclear accumulation. In contrast, NCZ or taxol treatment had no effect on nuclear accumulation of GFP-PTHrP-βGal-66-108 BASIC-1mut, confirming that MT-dependent nuclear import of PTHrP requires KKKK 91 . MT integrity is a critical determinant of the rate of PTHrP nuclear import-To confirm that the NLS/MTAS of PTHrP enhances its nuclear import rate in living cells, we performed FRAP analysis as previously (9, 16) . For this approach, the fluorescent signal in the nucleus is photobleached, enabling monitoring of the nuclear import rate by quantifying the return of fluorescence to the nucleus, which results from translocation of non-bleached, cytoplasmic fluorescent protein into the nucleus (22, 31, 42,  43) .
COS-7 cells were transfected to express GFPPTHrP-66-108-βgal or the BASIC-1mut derivative, and treated without or with NCZ, before analysis of nuclear import using FRAP (Fig. 5) . Figure 5C shows typical traces of the increase in nuclear fluorescence (Fn) subsequent to bleaching, together with the corresponding decline in cytoplasmic fluorescence (Fc). Nontreated WT GFP-PTHrP66-108-βgal shows a significant increase in Fn in parallel with a rapid decline in Fc. Upon treatment with NCZ, however, the increase of Fn is reduced, concomitant with slowed Fc decay, consistent with the idea that efficient PTHrP nuclear import requires MT integrity. In contrast, even in the absence of NCZ, the BASIC-1mut derivative shows a less robust post-bleach increase in Fn and a slower decay in Fc, whilst NCZ treatment has little effect (Fig. 5C ). Thus MT-dependent transport appears to be impaired in the mutant protein. Figure 5D shows the results in terms of the fractional recovery of Fn/c ratio (see Materials and Methods for details). After photobleaching, GFP-PTHrP-66-108-βgal accumulates rapidly in the nucleus of non-treated cells, with a half time for fractional recovery (t 1/2 ) of 51 s. Importantly, BASIC-1mut derivative shows a significantly (p < 0.0001) slower rate of recovery (t 1/2 of 93 s, see also Fig. 5F ), confirming that residues KKKK 91 are necessary for rapid and efficient nuclear import of PTHrP. Results for the initial rate of decay of cytoplasmic fluorescence (Fc) through transport to the nucleus (Fig. 5E ) confirmed this, indicating that the BASIC-1mut derivative has a c. 2-fold slower rate of nuclear import compared to WT (Fc s -1 of c. 0.7 compared to 1.5).
Cells treated with NCZ showed significantly reduced rate of nuclear import of GFP-PTHrP-66-108-βgal (t 1/2 of 118, Fig. 5F ), with the initial rate of decay of Fc similarly reduced ( Fig. 5E ; Fc s -1 of 0.60), consistent with the idea that efficient/rapid nuclear import of PTHrP 66-108 is dependent on MT integrity. In contrast, NCZ treatment had essentially no effect on the nuclear import rates of GFP-PTHrP-66-108-βgal BASIC-1mut (t 1/2 s of 91 and 93s in NCZ-treated and non-treated cells respectively), and the initial rates of cytoplasmic decay were identical in both conditions (Fc s -1 of c. 0.65). These results are consistent with the idea that MTdependent transport is essentially eliminated by this mutation. Clearly, WT PTHrP can traffic efficiently to the nucleus, dependent on MTs, and mutation of residues KKKK 91 impairs this, indicating that residues KKKK 91 are crucial for the MT-enhanced nuclear trafficking mechanism of PTHrP. (10) . The in vitro polymerized MT filaments were then incubated with bacterially-expressed GFPPTHrP fusion proteins (amino acids 38-108, 66-108, 82-108, 66-94), as well as mutant derivatives thereof and negative controls (GFP, GFP-T-ag NLS). Some assays were performed in the presence of GST-IMPs. The binding of the GFP fusion proteins to the MTs was analyzed by CLSM (see Material and Methods). Clear association of GFP-PTHrP-82-108, 38-108 and 66-108 but not 66-94 with the MTs filaments was observed, consistent with the idea that PTHrP 82-108 represents the minimal MTAS region of PTHrP (see above). Quantitative analysis to determine the specific MT-associated fluorescence (Fmt) relative to background fluorescence (Fb), supported these findings (Fig.  7C) , indicating significantly reduced (p < 0.0001; c. 10-fold less) binding to MTs by GFPPTHrP-66-94 compared to the other truncation derivatives. Mutation of KKKK 91 or KKRR 106 in GFP-PTHrP-66-108 reduced MT association ( Fig. 7A right panels, and 7C) by about 50%, demonstrating the dependence of MT association on these residues, and indicating that both basic regions are required for optimal MT association. The clear implication is that the NLS and MTAS are collinear/overlap. GFP and GFP-T-ag (which carries the same net positive charge as GFPPTHrP-66-108) both failed to associate with MTs ( Fig. 7A lower right panels) , confirming the specificity of the results.
KKKK
Interestingly, pre-incubation of PTHrP with GST-IMPβ1 but not GST-IMPα (see Fig. 7A , left panels) or GST alone (not shown), impaired the ability of all MT-associating PTHrP derivative proteins to interact with MTs, consistent with colinear/overlapping NLS and MTAS sequences and with the idea that both basic clusters are involved in IMP and MT binding.
Further investigation indicated that the MTassociation of PTHrP could be disrupted by a short incubation (10 min) of GST-IMPβ1 even after pre-binding (1h) of PTHrP to MTs, indicative of competitive binding (Fig. 7B right  panels) . Importantly, biotinylated GST-IMPβ1, detected using FITC-streptavidin, was found not to associate directly with polymerized MT filaments (not shown). This suggested that displacement of PTHrP from MTs is due to IMPβ1 binding to PTHrP and not to MTs at the same site as PTHrP. Overall, the results imply that IMPβ1's role in PTHrP trafficking in the cell may be to release PTHrP from MTs in the region of the MT organizing centre (MTOC) near the nuclear envelope where the local IMPβ1 concentration is high (46) , prior to translocating soluble PTHrP through the nuclear pore into the nucleus.
To confirm the association of PTHrP with MTs from living cells and IMPβ1's potential role in regulating this interaction, intact MTs were extracted from COS-7 cells expressing GFP-PTHrP fusions 66-108 (and mutant derivatives thereof), 82-108, 66-94, 94-108, GFP alone or myc-tagged human IMPβ1. In some cases, cells were cotransfected to express PTHrP derivatives with myc-IMPβ1. The presence of GFP-PTHrP and/or human IMPβ1 in isolated MT fractions was assessed by Western blotting and quantified by densitometry (Fig. 7D-G) . GFP-PTHrP-66-108, 82-108, LINKERmut and BASIC-2mut were all found to associate with MTs, although BASIC-2mut did so to a much lesser extent (see Fig. 7DE ), consistent with the results for in vitro MT binding (see above and Fig. 7C) . In contrast to GFP-PTHrP-66-94, 94-108, BASIC-1mut, and GFP alone showed no association with MTs (Fig. 7DE) .
Neither endogenous cellular (not shown) nor ectopically expressed human IMPβ1 was found in the MT fraction (Fig. 7DE) , indicating that IMPβ1 does not associate with MTs in vivo, consistent with the in vitro findings (see above). IMPβ1 is also not detectable in the MT fractions in which PTHrP is detected, consistent with the idea that the binding of PTHrP to MTs is mutually exclusive with its binding to IMPβ1.
To confirm that IMPβ1 could displace PTHrP from intact MTs in living cells, MTs were extracted from cells coexpressing PTHrP and myc-IMPβ1. GFP-PTHrP-66-108 association with MTs was found to be c. 2-fold lower in cells coexpressing mycIMPb than in cells expressing GFP-PTHrP-66-108 alone. The specificity of this effect to PTHrP 66-108 was indicated by the fact that no such effect of IMPβ1 coexpression on MT-association was observed for either BASIC-1mut or GFP alone (see Fig. 7FG ).
The results clearly imply that IMPβ1's ability to inhibit PTHrP binding to MTs (Fig. 7) is through IMPβ1 binding to PTHrP, and not through IMPβ1 competing for PTHrP's binding sites on MTs. The absence of IMPβ1 in the PTHrP-MT fraction indicates that although PTHrP is able to bind both IMPβ1 and MTs, it does not associate with IMPβ1 when bound to MTs in intact cells, consistent with the mutually exclusivity of binding observed in the in vitro assays (Fig. 7A-C) Endogenously expressed PTHrP relies on MT functionality for optimal nuclear localizationTo confirm that the results for ectopically expressed GFP-PTHrP fusion proteins are relevant to endogenous PTHrP, COS-7 and U2 OS osteosarcoma cell lines, which express PTHrP endogenously, were treated with or without NCZ or taxol before fixation and staining for PTHrP and quantitative CLSM analysis of its subcellular localization was performed (Fig. 8) . As expected, increased cytoplasmic localization of PTHrP was evident in the cells treated with NCZ or taxol (Fig. 8A) .
Quantitative analysis confirmed a significant (p < 0.05) 30-50% increase in cytoplasmic fluorescence (Fig. 8B, middle) , and a corresponding decrease in nuclear fluorescence in COS-7 cells treated with NCZ or Taxol compared with non-treated cells (Fig. 8B, left) . In both cell lines, this resulted in a significant (p < 0.0001) 50-60% reduction in the Fn/c value following MT depolymerization by NCZ or MT stabilization by taxol treatments (Fig. 8BC) . These treatments produced no detectable effect on the nuclear accumulation of endogenously expressed SV40 large tumor antigen (T-ag) in COS-7 cells, strongly implying that the effects observed for PTHrP were not attributable to general effects of the drugs on nuclear transport efficiency (see also (9) ). Overall, the results indicate that endogenously expressed PTHrP relies on functional/intact MTs for optimal nuclear accumulation.
DISCUSSION
Here we characterize for the first time the molecular mechanism underlying MT-dependent nuclear import of PTHrP. In so doing, we also define the first modular MTAS able to confer physical and functional MT association in nuclear import. Importantly, we establish the detailed mechanism of its action i.e. that it functions through the intriguing interplay between overlapping NLS and MTAS sequences to ensure efficient transfer of PTHrP from MTs to IMPβ1, and subsequent transport into the nucleus. MT-dependent nuclear import has been reported previously for a number of proteins (e.g. p53, Rb) (4, 9, 16, 17) , but the sequences responsible as well as the details of the trafficking mechanisms involved have remained unresolved. In particular, an MTAS sufficient to confer MT-association and enhancement of nuclear import per se has never previously been identified. The work described here defines such an MTAS for the first time, thereby shedding new light on the mechanisms underlying MTfacilitated nuclear transport.
We show here that optimal nuclear accumulation of PTHrP requires specific residues within 66-108, which includes overlapping IMPβ1-recognized NLS (66-108) and MTAS (82-108) sequences (see Fig. 3B ). The fact that the NLS and MTAS share key residues integral to their function ensures that IMPβ1 binding and MT association are mutually exclusive. This is documented here not only in our in vitro binding studies, but also by the subcellular fractionation experiments using transfected cells ( Fig.  8D-F) , where overexpression of IMPβ1 resulted in reduced association of PTHrP with MTs.
These results identify a mechanism by which PTHrP can be released from MTs subsequent to MT-dependent delivery to the perinuclear region. Specifically, it appears that PTHrP traffic to the nuclear region is accelerated by its association with MTs until arrival at the MTOC/perinuclear region, where IMPβ1's local concentration is highest (46) . This high concentration enables IMPβ1 to compete with MTs for PTHrP binding, thereby releasing PTHrP from the MT cytoskeleton prior to ferrying it through the nuclear pore into the nucleus. That IMPβ1 is not present in the MT fraction of intact cells (Fig. 8) is consistent with the idea that IMPβ1 acts in addition to/subsequent to MT-dependent transport of PTHrP. Importantly, the results explain for the first time how, through dynamic interactions with MTs, MTAS-dependent MT-interaction can facilitate nuclear import, rather than resulting in cytoplasmic sequestration and, consequently, inhibition of nuclear import (47) (48) (49) .
Efficient MT-dependent nuclear import of p53, Rb and several other cellular and viral proteins such as rabies virus P-protein (RPP) (4, 9, 16) , is dependent on dynein/dynactin, with preliminary data (not shown) indicating that MT-facilitated transport of PTHrP towards the nucleus also involves dynein. Since optimal PTHrP nuclear import is impaired in taxoltreated cells, the clear implication is that an intact MT network in itself is insufficient for facilitated import, but rather, a dynamic MT network may be required. A possible explanation is that MT dynamics contribute to the transfer of cargo between MTs and dynein, where PTHrP may first associate with MTs and then pass to dynein for trafficking. Whether the same mechanism relates to similar observations for MT-facilitated nuclear transport of p53 (4) and Rb (9) remains to be determined.
Interestingly, the MTAS responsible for MT association/ facilitated nuclear import, which is within PTHrP residues 82-108 and is critically dependent on the KKKK 91 and KKRR 106 basic clusters, is quite distinct from consensus motifs for DLC association (DLC-AS) (e.g. KSTQT and GIQVD for DLC8, and SKCSR for Tctex-1), which mediate MT-dependent nuclear import of proteins including RPP (16, (37) (38) (39) (50) (51) (52) (53) (54) . Although the latter appear to be able, out of context, to enhance conventional NLSdependent nuclear import (16), such sequences do not directly confer MT interaction, in contrast to the PTHrP MTAS examined here (55, 56) . Clearly, the PTHrP basic motifs responsible for PTHrP MT association differ markedly from defined consensus DLC-ASs, and mutation of PTHrP KEQE 101 , which can be postulated to resemble a DLC8 association motif, had no effect on PTHrP MT-dependent nuclear import. PTHrP fusion proteins also do not associate with DLC8 (not shown), further underlining the fact that MTASs and DLC-ASs are distinct.
In summary, this study has enhanced our understanding of the nuclear trafficking of cellular proteins with key roles in vital processes in physiology and transformation. In addition, it has established the mechanism of MT-dependent nuclear protein cargo delivery. This has clear implications for the design of vectors for nonviral gene delivery to the cell nucleus, for which cytoplasmic diffusion of large DNA molecules is a significant limiting factor (57, 58) . The fact that PTHrP 66-108 is a sequence module able to target a 580-kDa fusion protein (GFP-βgal) rapidly, and efficiently into the nucleus dependent on MT integrity (eg. 
FOOTNOTES
The abbreviations used are: CD, cytochalasin D; CLSM, confocal laser scanning microscopy; FRAP, fluorescence recovery after photobleaching; IMP, importin; MT, microtubule; MTAS, microtubule association sequence; NCZ, nocodazole; NLS, nuclear localization signal; NPC, nuclear pore complex; PTHrP, parathyroid hormone related protein; Rb, retinoblastoma protein. COS-7 cells expressing the indicated proteins were lysed in MT stabilizing buffer and subjected to ultracentrifugation. The MT pellet/associated proteins (P) were separated from supernatant (S)-containing soluble proteins and tubulin as described in Material and Methods and washed (W) 3 times prior to resuspension. Fractions were then subjected to Western analysis using the indicated antibodies. Densitometric analysis for the protein levels in D/F is presented (E, G), where the signal intensity above background for the GFP-fusion proteins in S and P are expressed relative to the corresponding values for tubulin, and the values then expressed as a percentage relative to that derived for the supernatant (100%) (in E) or the ratio of pellet/supernatant, relative to the maximum value (for wild type, single expression) (in G). by guest on September 16, 2017 
